VR Education in Arterial Hypertension

NCT ID: NCT05735808

Last Updated: 2023-07-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-07

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare standard education with VR augmented education in patients with arterial hypertension

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To demonstrate the technical and organizational feasibility of patient education about arterial hypertension in virtual reality. Demonstrate the non-inferiority of education conducted in virtual reality to traditional face-to-face education by a physician. To define the cost-effectiveness of education in virtual reality in the reality of progressing shortage of human resources.

Patients diagnosed with arterial hypertension as part of a routine examination in an internal medicine outpatient clinic will be randomized to education about the disease directly by a physician in one arm or using a 3D movie in VR glasses filmed by a physician in an identical outpatient clinic setting. It will be concluded by questionnaire method to compare the outcome of both education namely subjective satisfaction and objectively by using questions to evaluate the success of the education.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arterial Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standart physicain based education

In this arm, patient education will be conducted by the physician as the gold standard.

Group Type ACTIVE_COMPARATOR

Physician based education

Intervention Type BEHAVIORAL

Regular education provided by physician

VR based education

In this arm, patient education will be performed using 3D educational material presented in VR glasses.

Group Type EXPERIMENTAL

VR based education

Intervention Type BEHAVIORAL

VR based education

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physician based education

Regular education provided by physician

Intervention Type BEHAVIORAL

VR based education

VR based education

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all consecutive patients with arterial hypertension

Exclusion Criteria

* visual impairment
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Poliklinika Agel, Dopravni zdravotnictvi a.s.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bogna Jiravska Godula

PI

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Otakar Jiravsky

Role: STUDY_CHAIR

Nemocnice AGEL Trinec-Podlesi a.s.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Poliklinika Agel

Ostrava, , Czechia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bogna Jiravska Godula, MD

Role: CONTACT

+420602579193

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bogna Jiravska Godula, MD

Role: primary

+420724307894

Otakar Jiravský, MD

Role: backup

+420602579193

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PAgel

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mobile Health Management of Hypertension
NCT05856955 NOT_YET_RECRUITING NA
We Talk About Our Hypertension
NCT02483780 COMPLETED NA